Evidence map›Paper›PMID 40061424›Full record

ArticleFrontiers in pediatrics2025

Trend analysis of pediatric urolithiasis prevalence from 1990 to 2021 in the BRICS.

Zhi-Gang Zhang, Qing-Cheng Lin, Qing-Ying Zhou, Nai-Fen Xu, Ding-Qin Zheng, Qi-Zhuang Pan, Xin-Jun Wang, Ran Xu

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Role of UropathogenicPathogens (Basel, Switzerland) · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhi-Gang ZhangDepartment of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.
Qing-Cheng LinDepartment of Xiaojiang, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.
Qing-Ying ZhouDepartment of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.
Nai-Fen XuDepartment of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.
Ding-Qin ZhengDepartment of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.
Qi-Zhuang PanDepartment of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.
Xin-Jun WangDepartment of Urology, Zhongshan Hospital Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Ran XuDepartment of Urology, Pingyang Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The increasing epidemiological trend of pediatric urolithiasis over the past three decades has brought it to the forefront of public health attention. An analysis of the disease burden in Brazil, Russia, India, China, and South Africa (BRICS) countries, which share common characteristics such as large population base and limited public health resources, will provide an important reference for global public health policy development. Therefore, this study aimed to investigate the trend of the prevalence of pediatric urolithiasis in BRICS countries during 1990-2021, which in turn will provide more valuable information for them and the world in the prevention and treatment of pediatric urolithiasis. Methods: In this study, data were obtained from the Global Burden of Disease (GBD) database. The data were then statistically analyzed using the Joinpoint regression model, AutoRegressive Integrated Moving Average (ARIMA) prediction model, and subgroup analysis to assess trends in the prevalence of pediatric urolithiasis. Result: Globally, the prevalence has been increasing every year, with the greatest increase in the 10-14 age group. Encouragingly, the Age-Standardized Prevalence Rate (ASPR) has shown a decreasing trend. The disease burden of pediatric urolithiasis is higher in India and Russia, with the prevalence in India and ASPR in Russia being the highest in the BRICS countries. In South Africa, there is a clear deficit in prevention and treatment in the 0-4 year age group. Additionally, although the burden of pediatric urolithiasis in Brazil is not currently severe, the trend is the fastest deteriorating among the BRICS countries. Finally, China has made significant progress in the prevention and control of pediatric urolithiasis over the past 30 years and is expected to continue this positive trend over the next 15 years. Conclusion: This in-depth analysis based on GBD 2021 provides a fresh perspective on the evolving burden of pediatric urolithiasis in BRICS countries over the last three decades. Our research provides valuable insights for policy makers and health care providers through in-depth analysis and scientific evaluation of the prevalence of pediatric urolithiasis using different statistical models. In addition, BRICS countries should develop targeted prevention strategies for at-risk populations and ensure the availability of effective treatments that are tailored to their national contexts while also reflecting global health trends and evidence.

Indexed as

age-period-cohort analysisGlobal Burden of Diseasejoinpoint regressionprevalenceurolithiasis

Identifiers

PMID40061424
PMCPMC11885269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.